Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Companies enter deals to test drugs for diseases in the brain

December 3rd, 2003

Companies enter deals to test drugs for diseases in the brain

Abstract:
Designing therapeutic drugs to treat degenerative diseases such as Alzheimer’s and Lou Gehrig’s is challenging enough. But getting them past the protective blood-brain barrier and into brain tissue can prove mind-boggling.
Two biotechnology companies that specialize in nanoscale pharmaceuticals signed deals recently that may allow them to accomplish both feats. Advectus Life Sciences Inc. in Vancouver and C Sixty Inc. in Houston announced partnerships that could pave the way for therapies for Alzheimer’s, Lou Gehrig’s disease and other life-threatening conditions.

Source:
SmallTimes

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Chemists strike nano-gold: 4 new atomic structures for gold nanoparticle clusters: Research builds upon work by Nobel Prize-winning team from Stanford University April 28th, 2015

Self-assembling biomaterial forms nanostructure templates for human tissue formation April 27th, 2015

International research team discovers new mechanism behind malaria progression: Findings provide a new avenue for research in malaria treatment April 27th, 2015

Scientists join forces to reveal the mass and shape of single molecules April 27th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project